15/06/2009
15 June 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that Dr Michael Boss (General Manager, Autoimmune) will present an overview of the Company's strategy, programmes and prospects at the 3rd Annual Jefferies Healthcare Conference in New York on Thursday Jun 18th at 14:00 EDT/19:00 BST.
A webcast of the presentation will be available on Antisoma's website at http://www.antisoma.com/asm/media/webcast/
For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.
Enquiries:
Alison Saville
Communications Executive
Antisoma plc
+44 (0)20 3249 2100
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical
company that develops novel products for the treatment of cancer.
The Company has operations in the UK and the US. Please visit
www.antisoma.com for further
information about Antisoma.